These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29367096)

  • 1. Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET.
    Wagner M; Wuest M; Hamann I; Lopez-Campistrous A; McMullen TPW; Wuest F
    Nucl Med Biol; 2018 Mar; 58():51-58. PubMed ID: 29367096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-Generation Radiolabeled Cyclic Peptides for Molecular Imaging of Platelet-Derived Growth Factor Receptor α.
    Pike S; Wuest M; Lopez-Campistrous A; Hu MY; Derda R; Wuest F; McMullen T
    Mol Pharm; 2024 Sep; 21(9):4648-4663. PubMed ID: 39152916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-PET Imaging of EGFR with
    Sarrami N; Wuest M; Paiva IM; Leier S; Lavasanifar A; Wuest F
    Mol Pharm; 2024 Nov; 21(11):5797-5806. PubMed ID: 39402973
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting Phosphatidylserine with a
    Perreault A; Richter S; Bergman C; Wuest M; Wuest F
    Mol Pharm; 2016 Oct; 13(10):3564-3577. PubMed ID: 27608290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine activation of platelet-derived growth factor receptor α in metastatic papillary thyroid cancer.
    Adewuyi EE; Deschenes J; Lopez-Campistrous A; Kattar MM; Ghosh S; McMullen TPW
    Hum Pathol; 2018 May; 75():146-153. PubMed ID: 29408504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Detection of HER2 Expression in Gastric Cancer by
    Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z
    Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
    England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
    Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring pitfalls of
    Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
    Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.
    Luo H; Hong H; Slater MR; Graves SA; Shi S; Yang Y; Nickles RJ; Fan F; Cai W
    J Nucl Med; 2015 May; 56(5):758-63. PubMed ID: 25840981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
    Ghosh SC; Pinkston KL; Robinson H; Harvey BR; Wilganowski N; Gore K; Sevick-Muraca EM; Azhdarinia A
    Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TE1PA as Innovating Chelator for
    Navarro AS; Le Bihan T; Le Saëc P; Bris NL; Bailly C; Saï-Maurel C; Bourgeois M; Chérel M; Tripier R; Faivre-Chauvet A
    Bioconjug Chem; 2019 Sep; 30(9):2393-2403. PubMed ID: 31386357
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kwon LY; Scollard DA; Reilly RM
    Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
    Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A
    J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice.
    Aghevlian S; Wu B; Raie MN; Tumbale SK; Kare AJ; Seo JW; Ferrara KW
    Nucl Med Biol; 2021; 98-99():8-17. PubMed ID: 33962357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging.
    Mayer AT; Natarajan A; Gordon SR; Maute RL; McCracken MN; Ring AM; Weissman IL; Gambhir SS
    J Nucl Med; 2017 Apr; 58(4):538-546. PubMed ID: 27980047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).
    Fournier P; Dumulon-Perreault V; Ait-Mohand S; Tremblay S; Bénard F; Lecomte R; Guérin B
    Bioconjug Chem; 2012 Aug; 23(8):1687-93. PubMed ID: 22770480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
    Dearling JL; Voss SD; Dunning P; Snay E; Fahey F; Smith SV; Huston JS; Meares CF; Treves ST; Packard AB
    Nucl Med Biol; 2011 Jan; 38(1):29-38. PubMed ID: 21220127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition.
    Ekpe-Adewuyi E; Lopez-Campistrous A; Tang X; Brindley DN; McMullen TP
    Oncotarget; 2016 Dec; 7(50):83684-83700. PubMed ID: 27845909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.
    Luo H; England CG; Graves SA; Sun H; Liu G; Nickles RJ; Cai W
    J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.